Ken N. Wills

2.1k total citations
28 papers, 1.8k citations indexed

About

Ken N. Wills is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ken N. Wills has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Genetics and 9 papers in Oncology. Recurrent topics in Ken N. Wills's work include Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers) and Estrogen and related hormone effects (7 papers). Ken N. Wills is often cited by papers focused on Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers) and Estrogen and related hormone effects (7 papers). Ken N. Wills collaborates with scholars based in United States, Germany and India. Ken N. Wills's co-authors include Magnus Pfahl, Xiao-kun Zhang, Maty Tzukerman, Gerhart Graupner, Thomas Hermann, Duane E. Johnson, Daniel C. Maneval, Richard J. Gregory, Suganto Sutjipto and Robert Bookstein and has published in prestigious journals such as Nature, Circulation and Molecular and Cellular Biology.

In The Last Decade

Ken N. Wills

28 papers receiving 1.7k citations

Peers

Countries citing papers authored by Ken N. Wills

Since Specialization

Citations

This map shows the geographic impact of Ken N. Wills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken N. Wills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken N. Wills more than expected).

Fields of papers citing papers by Ken N. Wills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken N. Wills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken N. Wills. The network helps show where Ken N. Wills may publish in the future.

Co-authorship network of co-authors of Ken N. Wills

This figure shows the co-authorship network connecting the top 25 collaborators of Ken N. Wills. A scholar is included among the top collaborators of Ken N. Wills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken N. Wills. Ken N. Wills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens 2008 ·Vaccine ·Alain Luxembourg, Drew Hannaman, Ken N. Wills, R Bernard, Bud C. Tennant, Stephan Menne, Paul J. Côté	18
2	Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors 2005 ·Virology ·John A. Howe, Peter Pelka, (unknown), (unknown), (unknown), (unknown), Murali Ramachandra, Jenny B. Avanzini, Mark Horn, Ken N. Wills, Suganto Sutjipto, Robert Ralston	7
3	Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice 2003 ·Molecular Therapy ·Heidrun Engler, Todd Machemer, Thomas Schluep, Shu-Fen Wen, Erlinda Quijano, Ken N. Wills, (unknown), Daniel C. Maneval, (unknown)	10
4	Selective Expression of Nonsecreted Interferon by an Adenoviral Vector Confers Antiproliferative and Antiviral Properties and Causes Reduction of Tumor Growth in Nude Mice 2001 ·Journal of Interferon & Cytokine Research ·C. M. Iqbal Ahmed, Ken N. Wills, Barry J. Sugarman, Duane E. Johnson, Murali Ramachandra, (unknown), John A. Howe	27
5	Enhanced Apoptotic Activity of a p53 Variant in Tumors Resistant to Wild-Type p53 Treatment 2001 ·Molecular Therapy ·Isabella Atencio, Jenny B. Avanzini, Duane E. Johnson, Saskia Neuteboom, (unknown), Loretta L. Nielsen, (unknown), Suganto Sutjipto, Barry J. Sugarman, Jennifer Philopena, (unknown), (unknown), (unknown), Murali Ramachandra, Ken N. Wills	7
6	Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo 2001 ·Cancer Gene Therapy ·Xiaomei Jin, (unknown), Ken N. Wills, Jenny B. Avanzini, Van Tsai, Drake LaFace, (unknown), Bin Shi, Loretta L. Nielsen	38
7	Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers 2001 ·Cancer Gene Therapy ·C. M. Iqbal Ahmed, Duane E. Johnson, G W Demers, (unknown), John A. Howe, Ken N. Wills, Shu-Fen Wen, (unknown), (unknown), (unknown), Todd Machemer, (unknown), (unknown), Barry J. Sugarman	33
8	Intratumoral Spread and Increased Efficacy of a p53-VP22 Fusion Protein Expressed by a Recombinant Adenovirus 2001 ·Journal of Virology ·Ken N. Wills, Isabella Atencio, Jenny B. Avanzini, Saskia Neuteboom, Anne M. Phelan, Jennifer Philopena, Suganto Sutjipto, Mei Vaillancourt, Shu Fen Wen, Robert Ralston, Duane E. Johnson	44
9	In Vivo Tumor Suppression by Adenovirus-Mediated Interferon alpha2b Gene Delivery 1999 ·Human Gene Therapy ·C. M. Iqbal Ahmed, Barry J. Sugarman, Duane E. Johnson, (unknown), (unknown), (unknown), Ken N. Wills	21
10	Adenoviral Constructs Encoding Phosphorylation-Competent Full-length and Truncated Forms of the Human Retinoblastoma Protein Inhibit Myocyte Proliferation and Neointima Formation 1997 ·Circulation ·Roy C. Smith, Ken N. Wills, (unknown), Harris Perlman, (unknown), Kevin Krasinski, Kenneth Walsh	56
11	p53 gene therapy in vivo of herpatocellular and liver metastatic colorectal cancer. 1996 ·PubMed ·Robert Bookstein, (unknown), Richard J. Gregory, Daniel C. Maneval, (unknown), Ken N. Wills	35
12	Adenovirus-mediatedp53 gene transfer suppresses growth of human glioblastoma cellsin vitro andin vivo 1996 ·International Journal of Cancer ·(unknown), Matthew P. Harris, Scott C. Anderson, Todd Machemer, (unknown), Suganto Sutjipto, Ken N. Wills, Richard J. Gregory, H. Michael Shepard, Manfred Westphal, Daniel C. Maneval	80
13	Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo 1996 ·International Journal of Cancer ·(unknown), (unknown), Scott C. Anderson, Todd Machemer, (unknown), Suganto Sutjipto, Ken N. Wills, Richard J. Gregory, (unknown), Manfred Westphal, Daniel C. Maneval	6
14	Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer 1994 ·Human Gene Therapy ·Ken N. Wills, Daniel C. Maneval, Patricia Menzel, (unknown), Suganto Sutjipto, (unknown), (unknown), Duane E. Johnson, Scott C. Anderson, Shu Fen Wen, Robert Bookstein, H. Michael Shepard, Richard J. Gregory	204
15	Regulatory functions of a non-ligand-binding thyroid hormone receptor isoform. 1991 ·PubMed ·Thomas Hermann, X K Zhang, Maty Tzukerman, Ken N. Wills, Gerhart Graupner, Magnus Pfahl	31
16	Thyroid Hormone Receptors Repress Estrogen Receptor Activation of a TRE 1991 ·Molecular Endocrinology ·Gerhart Graupner, Xiao-kun Zhang, Maty Tzukerman, Ken N. Wills, Thomas Hermann, Magnus Pfahl	55
17	Coordinate Expression of Functionally Distinct Thyroid Hormone Receptor α Isoforms during Neonatal Brain Development 1991 ·Molecular Endocrinology ·Ken N. Wills, Xiao-kun Zhang, Magnus Pfahl	21
18	Changes in phosphofructokinase isozymes during development of myoblasts to myotubes 1990 ·Archives of Biochemistry and Biophysics ·Ken N. Wills, Tag E. Mansour	2
19	[26] Nuclear retinoic acid receptors: Cloning, analysis, and function 1990 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Magnus Pfahl, Maty Tzukerman, Xiao-kun Zhang, (unknown), Thomas Hermann, Ken N. Wills, Gerhart Graupner	71
20	Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity 1989 ·Nature ·Gerhart Graupner, Ken N. Wills, Maty Tzukerman, Xiao-kun Zhang, Magnus Pfahl	274

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact